Literature DB >> 20506068

European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.

J-M Dumonceau1, A Andriulli, J Deviere, A Mariani, J Rigaux, T H Baron, P A Testoni.   

Abstract

Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Risk factors for post-ERCP pancreatitis (PEP) are both patient-related and procedure-related. Identification of patients at high risk for PEP is important in order to target prophylactic measures. Prevention of PEP includes administration of nonsteroidal inflammatory drugs (NSAIDs), use of specific cannulation techniques, and placement of temporary pancreatic stents. The aim of this guideline commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) is to provide practical, graded, recommendations for the prevention of PEP. Georg Thieme Verlag KG Stuttgart.New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20506068     DOI: 10.1055/s-0029-1244208

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  69 in total

Review 1.  Endoscopic complications--avoidance and management.

Authors:  Daniel Blero; Jacques Devière
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 46.802

2.  Therapy: can rectal NSAIDs prevent post-ERCP pancreatitis?

Authors:  Pier Alberto Testoni
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 46.802

3.  Post-endoscopic retrograde cholangiopancreatography complications: How can they be avoided?

Authors:  Juan J Vila; Everson L A Artifon; Jose Pinhata Otoch
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

4.  Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis.

Authors:  Toshio Fujisawa; Koichi Kagawa; Kantaro Hisatomi; Kensuke Kubota; Hajime Sato; Atsushi Nakajima; Nobuyuki Matsuhashi
Journal:  J Gastroenterol       Date:  2016-01-20       Impact factor: 7.527

5.  Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center.

Authors:  Chong Wang; Qirui Li; Peng Ye; Sheng Zeng; Guo-Hua Li; You-Xiang Chen; Xiao-Jiang Zhou; Nong-Hua Lv
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

6.  Chemoprevention of Post-ERCP Pancreatitis with Rectal NSAIDs: Does Poking Both Ends Justify the Means?

Authors:  Tilak Shah; Alvin Zfass; Mitchell L Schubert
Journal:  Dig Dis Sci       Date:  2015-06-23       Impact factor: 3.199

7.  Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis: from divination to science.

Authors:  Sung-Hoon Moon; Myung-Hwan Kim
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

Review 8.  Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?

Authors:  Young Koog Cheon
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

9.  No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

Authors:  Hirotoshi Ishiwatari; Takahiro Urata; Ichiro Yasuda; Shimpei Matsusaki; Hiroyuki Hisai; Hiroshi Kawakami; Michihiro Ono; Takuji Iwashita; Shinpei Doi; Kazumichi Kawakubo; Tsuyoshi Hayashi; Tomoko Sonoda; Naoya Sakamoto; Junji Kato
Journal:  Dig Dis Sci       Date:  2016-07-22       Impact factor: 3.199

Review 10.  Is endoscopic papillary balloon dilatation really a risk factor for post-ERCP pancreatitis?

Authors:  Toshio Fujisawa; Koichi Kagawa; Kantaro Hisatomi; Kensuke Kubota; Atsushi Nakajima; Nobuyuki Matsuhashi
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.